ADHD 360 ADHD & Autism Assessment & Treatment Service
Keep momentum on this opportunity
Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.
- Save and reuse search filters
- Track opportunities as pursuits
- Get notified when new notices match
Keep this notice in a shortlist so you can return to it without starting a bid.
Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.
Key information
Overview
Provision of ADHD and Autism assessment service for children, young people and adults in Bristol, North Somerset and South Gloucestershire. Provider will also be required to titrate and medicate patients diagnosed with ADHD who wish to receive pharmacological treatment.
Award Decision made by - Jenny Falco, Associate Director of Acute and IS No conflicts of interest were identified or declared during the process NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board (ICB) and Gloucestershire ICB are currently working together in a formal "clustering" arrangement to prepare for their merger into a single, new organisation (name to be confirmed), effective from 1st April 2027. This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
The provider will offer an ADHD and Autism assessment service. Patients receiving a diagnosis of ADHD and wishing to begin pharmacological treatment will be offered titration and follow up medication appointments, until they are stabilised on an appropriate dose. The provider will then either retain the patient for ongoing prescribing and review or, if their GP practice is signed up to the Shared Care Local Enhanced Service in BNSSG, they will be discharged back to primary care to manage this. Patients diagnosed with Autism will be offered some Post Diagnostic Support, although this may be limited to signposting to appropriate local organisations. The award has been made following Direct Award Process B. The procurement has been conducted in line with Right to Choose requirements. This is an activity-based contract with no guaranteed value. The contract has been awarded for the period 01/04/2026 - 31/03/2027 without a provision for extension included NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board (ICB) and Gloucestershire ICB are currently working together in a formal "clustering" arrangement to prepare for their merger into a single, new organisation (name to be confirmed), effective from 1st April 2027. Options: The ICB and provider may agree a further Direct Award B at the end of the current contract term.
Public Contracts Regulations 2015 (Directive 2014/24/EU)
Award procedure without prior publication of a call for competition The procurement has been conducted in line with Right to Choose requirements.
Lot 1: Bids: 1